Anti-angiogenic therapy based on the binding to receptors
From MaRDI portal
(Redirected from Publication:447948)
Positive solutions to PDEs (35B09) Bifurcations in context of PDEs (35B32) Initial-boundary value problems for second-order parabolic systems (35K51) Reaction-diffusion equations (35K57) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Cell movement (chemotaxis, etc.) (92C17)
Recommendations
- A therapy inactivating the tumor angiogenic factors
- The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- Closed-loop control of tumor growth by means of anti-angiogenic administration
- A cancer treatment based on synergy between anti-angiogenic and immune cell therapies
- Targeting tumour vasculature as a cancer treatment
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors
- Tumor development under combination treatments with anti-angiogenic therapies
Cited in
(5)- On the numerical solution to a parabolic-elliptic system with chemotactic and periodic terms using generalized finite differences
- A therapy inactivating the tumor angiogenic factors
- On a chemotaxis model with competitive terms arising in angiogenesis
- Mathematical modeling of VEGF binding, production, and release in angiogenesis
- Optimal control of a chemotaxis equation arising in angiogenesis
This page was built for publication: Anti-angiogenic therapy based on the binding to receptors
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q447948)
